Foley Hoag Attorney Ross Margulies Speaks at Q1 Pharmaceutical Strategic Patient Access and Support Conference
February 10, 2015
Foley Hoag LLP attorney Ross Margulies was a featured speaker at the Q1 Pharmaceutical Strategic Patient Access and Support Conference on February 10. His session, "Positioning Access & Support Programs in States Opting Out of Medicaid Expansion," examined the landscape and strategies behind the U.S. states that have refused to expand Medicaid coverage, as well as the rules that will be set forth to these states.
The Q1 Pharmaceutical Strategic Patient Access & Support Conference provides an annual forum for executives across the pharmaceutical industry to network and share ideas with peers. Margulies was among the top professionals on hand during the two-day conference who offered workshops and exchange groups on the most top-of-mind issues concerning patient access professionals today.
Margulies’ practice at Foley Hoag focuses on statutory and regulatory issues involving the Centers for Medicare & Medicare Services (CMS) and general health policy matters. His expertise includes Medicare and Medicaid reimbursement issues for innovative pharmaceutical products; and legal, regulatory and strategic advice for Medicare and Medicaid providers. Prior to joining the firm, Margulies served as a senior research associate at the George Washington University School of Public Health and Human Services, where his research focused almost exclusively on complex legal issues impacting the Medicaid program.
About Foley Hoag LLP
Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.